EXHIBIT 11
NANOPIERCE TECHNOLOGIES, INC. AND SUBSIDIARY
COMPUTATION OF NET LOSS PER SHARE
<TABLE>
<CAPTION>
Years ended June 30,
--------------------
2000 1999
---- ----
<S> <C> <C>
Net loss $(3,743,305) (3,139,439)
Dividends on Series A and B preferred stock - ( 160,633)
--------- ---------
Net loss applicable to common shareholders $(3,743,305) (3,300,072)
========= =========
Weighted average number of common shares
outstanding 32,709,638 14,457,613
Common equivalent shares representing
shares issuable upon exercise of
outstanding options and warrants - -
---------- ----------
32,709,638 14,457,613
========== ==========
Basic and diluted loss per share applicable
to common shareholders $( .11) ( .23)
========= =========
Stock options and warrants are not considered in the calculation as the impact
of the potential common shares (16,154,500 shares at June 30, 2000 and
5,345,000 shares at June 30, 1999) would be too decrease loss per share.
</TABLE>
<PAGE>